Symbol
| PCDH8
| contributors: mct - updated : 20-11-2019
|
HGNC name
| protocadherin 8
|
HGNC id
| 8660
|
Other morbid association(s)
|
Type | Gene Modification | Chromosome rearrangement | Protein expression | Protein Function
|
---|
tumoral
|  
|  
|  
| loss of function
|
by promoter region methylation in primary renal cell carcinoma | tumoral
|  
|  
|  
| loss of function
|
through either mutation or epigenetic silencing in a high fraction of breast carcinomas | tumoral
|  
|  
|  
| loss of function
|
by tumor-suppressive function of PCDH8 and epigenetic inactivation due to promoter methylation in hypopharyngeal carcinoma | tumoral
|  
|  
|  
| loss of function
|
often inactivated by promoter methylation in liver cancer | tumoral
|  
|  
|  
| loss of function
|
PCDH8 methylation may be associated with tumor progression and poor prognosis in non-muscle invasive bladder cancer (NMIBC) | |
Variant & Polymorphism
|
| |
Candidate gene
| candidate tumor suppressor and play a crucial role in the progression of Ovarian carcinoma |
Marker
| may serve as a useful prognostic biomarker for hypopharyngeal carcinoma patients |
|
PCDH8 methylation can serve as a valuable diagnostic biomarker for early detection of liver cancer and might be useful to predict an unfavorable clinical feature |
Therapy target
|
System | Type | Disorder | Pubmed |
cancer | head and neck | | |
potential therapeutic target for hypopharyngeal carcinoma patients |
| |